Drug Pipeline

TAK-788 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
1
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04129502 TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell… Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Active, Not Recruiting
Phase 1/2
NCT02716116 A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer Carcinoma, Non-Small-Cell Lung Active, Not Recruiting
Phase 1
NCT03807778 A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer Active, Not Recruiting
Sponsors Running TAK-788 Trials
Takeda (3)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (3) Lung Cancer (2)
Get alerts when TAK-788 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free